Thomas Illingworth
| Name | Thomas Illingworth |
|---|---|
| Job title | Lecturer in Biomedical Sciences & Public Health |
| Research institute | College of Science and Engineering |
| ORCID | https://orcid.org/0000-0001-9762-5071 |
Research outputs
Targeting hPKM2 in cancer: a bio isosteric approach for ligand design
Pipitò.L, Illingworth, T.A and Deganutti.G 2023. Targeting hPKM2 in cancer: a bio isosteric approach for ligand design. Computers in Biology and Medicine. 158, pp. 1-9. https://doi.org/10.1016/j.compbiomed.2023.106852Bacterial Interactions Affecting Chemotherapy Effectiveness
Chambers, J.M and Illingworth, T. 2023. Bacterial Interactions Affecting Chemotherapy Effectiveness. McGill Science Undergraduate Research Journal. 18 (1), pp. 15 - 18. https://doi.org/10.26443/msurj.v18i1.190Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques—an in silico study
Rock, M., Zouganelis, G., Belchior de Andrade, A., Drake, S., Alexiou, A., Albrakati, A., Bathia, G. E. S. and Illingworth, T. 2022. Development and validation of anti-human Alpha synuclein DNA aptamer using computer modelling techniques—an in silico study. Journal of Integrative Neuroscience. 21 (1), p. 5. https://doi.org/10.31083/j.jin2101005The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA
Howe, Michael, Illingworth, Thomas, Milton, Nathaniel, Paterson, Andrew, Gomez-Escalada, Margarita and Cussell, Peter.J.G 2019. The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA. PLos ONE. https://doi.org/10.1371/journal.pone.021781596
total views of outputs44
total downloads of outputs1
views of outputs this month0
downloads of outputs this month